Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion Effect on MEP Thresholds in Spine Surgery
NCT06792474Phase 4Not yet recruiting
- Sponsor
- Dartmouth Health
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Dartmouth Health. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06792474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06792474.